Jun Arii
Kobe, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 62 publications
Conserved U14-Mediated NF-κB Activation in Human Herpesvirus 6A and 6B.
Journal: Microbiology and immunology
Published: February 09, 2026
A viral APOBEC3 antagonist distinguishes HHV-6A from HHV-6B.
Journal: Nature communications
Published: July 11, 2025
Comparative Analysis of the Nuclear Egress Complex in Human Herpesvirus 6A and 6B.
Journal: Microbiology and immunology
Published: June 16, 2025
HHV-6B ribonucleotide reductase sequesters NF-κB subunit p65 to inhibit innate immune responses.
Journal: iScience
Published: June 18, 2024
Human herpesvirus 6A nuclear matrix protein U37 interacts with heat shock transcription factor 1 and activates the heat shock response.
Journal: Journal of virology
Published: September 06, 2023
Fourth mRNA vaccination increases cross-neutralizing antibody titers against SARS-CoV-2 variants, including BQ.1.1 and XBB, in a very elderly population.
Journal: Journal of infection and public health
Published: January 09, 2023
ATF1 Restricts Human Herpesvirus 6A Replication via Beta Interferon Induction.
Journal: Journal of virology
Published: September 26, 2022
The Number of Coronavirus Disease 2019 Vaccine Doses and Severe Clinical Outcomes in Older Patients Infected With a Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant.
Journal: The Journal of infectious diseases
Published: August 15, 2022
Assessment of Neutralizing Antibody Response Against SARS-CoV-2 Variants After 2 to 3 Doses of the BNT162b2 mRNA COVID-19 Vaccine.
Journal: JAMA network open
Published: May 09, 2022
Induction of High Neutralizing Activity Against Both Omicron BA.2 and Omicron BA.1 by Coronavirus Disease 2019 Messenger RNA Booster Vaccination.
Journal: The Journal of infectious diseases
Published: April 07, 2022
Last Updated: 09/26/2026